Scheduled In-house

Biopharma Training Courses

Biopharmaceuticals, known colloquially as biopharma, are the point at which biotechnology and pharmaceutical manufacturing meet. Biopharma is the application of living organisms or extractions, by-products or components of living organisms, to prevent, relieve, or treat diseases.

IPI Academy’s biopharma training courses provide an extensive series of training opportunities covering a variety of topics, including the development of biopharmaceuticals, clinical trial requirements, manufacture, regulations and applicable standards. Our courses also provide insight into the use of emerging technologies and state-of-the-art processes.  

View calendar Need help? 

  • Next: 10-11 Jul 2024 Live online
  • Also: 1-2 Oct 2024 Live online

Biosimilars

Live online

A two-day seminar providing an essential overview of biosmilars and how they differ from the original biological product.

  • 12 CPD hours Focused
  • Presented by Andrew Willis
  • Next: 24-26 Apr 2024 Classroom
  • Also: 24-28 Jun 2024 Live online
  • Also: 25-27 Sep 2024 Classroom
  • Also: 2-6 Dec 2024 Live online

Biotechnology for the Non-Biotechnologist

Live online, Classroom

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.

  • 18 CPD hours Focused
  • Presented by Mardon McFarlane
  • + 7 more
  • Next: 27-28 Jun 2024 Live online
  • Also: 17-18 Oct 2024 Live online

Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products

Live online

The regulatory requirements for Biological drug products are complex, and pharmaceutical companies are continuously under pressure to ensure regulatory compliance from drug discovery to post-marketing surveillance. This course has been designed to help you navigate the complex regulatory requirements for biological drugs, including ATMPs. It will clearly depict the differences between small and large molecules and the development approaches which reflect the type of molecule. It will address the key aspects of the CTD, look at the CMC regulatory requirements during different stages of development, and discuss the importance of change control.

  • 12 CPD hours Focused
  • Presented by Andrew Willis
  • Next: 4 Jun 2024 Live online
  • Also: 8 Oct 2024 Live online

Delivery of Biologics to the Nasal Cavity

Live online

The nasal cavity is an established pathway to treat local diseases as well as systemic conditions using small molecules. As the pharmaceutical industry shifts towards targeted biologics, the nasal cavity is also an attractive target for delivery of peptides, monoclonal antibodies, nucleic acids and stem cells. This is an ideal opportunity to hear from experts in the field of nasal drug delivery who will address topics such as: challenges associated with formulation, barriers to cell penetration and absorption, the pros and cons for liquid versus powder formulations, and strategies for maintaining stability and prolonging retention in the nasal cavity.

  • 3 CPD hours Focused
  • Presented by Dr Irene Rossi
  • + 3 more
  • Next: 17-18 Jul 2024 Live online
  • Also: 19-22 Nov 2024 Live online

An Introduction to ISO 22716 - GMP for Cosmetic Products

New for 2024

Live online

This course will provide an essential overview of GMP in the production and manufacture of cosmetics. It will be particularly useful for Pharmaceutical and Biotech companies considering entering this market and it will also provide an opportunity for those who need to refresh their knowledge about the requirements.

  • 12 CPD hours Focused
  • Presented by Mustafa Edik
  • Next: 12 Jul 2024 Live online
  • Also: 27 Nov 2024 Live online

US FDA - Understanding Key Factors When Working with the FDA

New for 2024

Live online

This course has been designed to provide an essential overview of the critical factors when working with the FDA (Food and Drug Administration).  For those short on time this course is for you, as you will receive a focused and comprehensive overview of the key strategic considerations when making applications to the FDA.  

  • 6 CPD hours Focused
  • Presented by Andrew Willis